China and the United States have opened high-level economic and trade talks in New York with a narrow but consequential agenda: extending a tariff truce, managing export controls on advanced technology and critical minerals, and limiting disruption to commercial ties that both governments still consider strategically useful.
China’s Commerce Ministry said Vice Premier He Lifeng would lead a delegation to the United States from Sept. 19 to 23. U.S. Treasury Secretary Scott Bessent led the American side, joined by U.S. Trade Representative Jamieson Greer, at a meeting held at JPMorgan’s headquarters on Sept. 20, according to the supplied report.
The negotiations precede a Sept. 24 state dinner for China’s leader at the White House, which the White House confirmed. The dinner would follow a leaders’ meeting held in May and places senior political engagement immediately after the trade discussions, creating a short timetable for officials to identify areas where an agreement or interim understanding may be possible.
Two dates are likely to frame the talks. The current tariff truce is due to expire on Nov. 10, while export restrictions covering rare earths and other key minerals remain a central source of uncertainty for companies that rely on China-linked supply chains. A truce extension would avoid an automatic return to higher tariffs, while more predictable minerals rules could help manufacturers plan procurement for electronics, electric vehicles and defense-related equipment.
Technology controls and minerals are at the center
Artificial intelligence safety, technology export restrictions, tariff arrangements, rare-earth supply and a potential trade purchasing list are among the issues on the table, according to the supplied report. The combination shows how the relationship has moved toward sector-by-sector bargaining rather than a single comprehensive trade settlement.
Washington has increasingly sought to restrict China’s access to selected advanced computing technologies while maintaining commercial links in areas considered less sensitive. Beijing, meanwhile, has used its position in critical-mineral processing to gain leverage in discussions over technology restrictions and tariffs.
Rare earth elements are used in products ranging from electric motors and wind turbines to semiconductors and precision electronics. Export controls or licensing delays can therefore affect manufacturers well beyond the mining sector. A stable framework would not eliminate strategic competition, but it could reduce the risk that supply-chain decisions are dictated by sudden policy shifts.
The timing also puts corporate leaders from the technology sector close to the diplomatic process. Nvidia Chief Executive Officer Jensen Huang, OpenAI Chief Executive Officer Sam Altman, Qualcomm Chief Executive Officer Cristiano Amon and Apple Chief Executive Officer Tim Cook are expected to attend the Sept. 24 dinner, according to the supplied article. Their presence would bring companies directly exposed to semiconductor rules, AI policy and Chinese consumer demand into the orbit of the negotiations.
The Chinese business delegation is expected to include representatives from BYD, Xiaomi, CATL, Gotion High-Tech, Hisense, Wanxiang Group, Bank of China and COFCO. The group spans electric vehicles, batteries, consumer electronics, banking, industrial supply chains and agricultural trade—the same commercial areas most exposed to tariffs, export rules and market-access questions.
Markets respond to improving dialogue
U.S.-listed Chinese shares rose after China’s Commerce Ministry announced He’s visit on Sept. 17, outperforming the Dow Jones Industrial Average in the latest session referenced in the report. The Nasdaq Golden Dragon China Index gained 0.76%, compared with a 0.18% decline for the Dow, a 0.17% gain for the S&P 500 and a 0.39% rise for the Nasdaq Composite.
The gains were concentrated in Alibaba and companies connected to data centers and cloud infrastructure, including GDS Holdings and VNET Group. Alibaba’s upcoming Apsara Conference also drew attention, reflecting market focus on whether China’s large technology groups can continue expanding AI and cloud services under tighter access to leading-edge chips.
Consumer and e-commerce shares were more muted, according to the report. That pattern suggests traders were treating the talks primarily as a potential reduction in policy risk for technology infrastructure and cross-border supply chains rather than as a broad signal of stronger Chinese consumption.
The yuan strengthened as well. Both onshore and offshore rates moved through 6.70 per U.S. dollar on Sept. 18, their strongest levels since February 2023, according to the supplied report. The move was linked to resilient exports and corporate conversion of foreign-currency receipts into yuan. Currency strength can ease the local-currency cost of imports, although a sustained appreciation would also affect the competitiveness of exporters.
Beijing adds digital infrastructure measures
Beijing has also released what was described as China’s first provincial-level “token economy ten measures,” including plans to support “token factories.” The terminology appears to refer to the packaging and distribution of digital resources for industrial and AI-related use, rather than a direct policy endorsement of tradable cryptocurrency tokens.
The reported program includes a target of 130,000 petaflops of intelligent computing capacity by the end of the year. A petaflop measures one quadrillion computing operations per second. Such capacity is relevant for training and operating AI systems, particularly for cloud providers and industrial software platforms that need access to large-scale data processing.
Morgan Stanley raised its forecast for monetizable consumer-facing AI revenue in China, according to the supplied report. The forecast aligns with the market’s attention on cloud infrastructure, but commercial AI growth will remain constrained by access to advanced chips, electricity, data-center capacity and the rules governing model deployment.
Treasury reportedly weighs targeted biotech restrictions
The negotiations are unfolding alongside a separate U.S. policy review involving pharmaceutical investment. Reuters reported on Sept. 18, citing three people familiar with the matter, that the Treasury Department is drafting rules addressing China-related pharmaceutical transactions.
Reuters said the proposed approach would allow U.S. drugmakers to continue most licensing deals involving Chinese pharmaceutical assets while restricting transactions related to pathogens or biotechnology that could be weaponized. The affected licensing market could be worth several billion dollars, according to the Reuters report.
The reported framework mirrors the logic visible in the New York talks: preserve ordinary commercial activity where possible while imposing tighter boundaries around technologies judged to carry national-security risks. For multinational companies, that approach may offer more room to operate than blanket restrictions, though it also requires them to assess whether individual technologies fall inside increasingly sensitive categories.
The immediate test will be whether officials can carry enough progress from New York into the Sept. 24 White House meeting to support a tariff extension before Nov. 10. Even a limited agreement on tariffs and mineral-export procedures would give technology, manufacturing and pharmaceutical companies a clearer operating environment while leaving the hardest disputes over AI capabilities and advanced chips unresolved.
For deeper context on tariff shifts’ impact on crypto, explore our market insight in this analysis today.
Disclaimer: The content on this page is provided for general informational purposes only and does not represent the views or financial advice of Toobit. We make no guarantees regarding the accuracy or completeness of this information and shall not be held liable for any errors, omissions, or outcomes resulting from its use. Investing in digital assets involves risk; users should independently evaluate their financial situation and the risks involved. For further details, please consult our Terms of Service and Risk Disclosure.
